Mammalian Biologics CDMO Services

Biomanufacturing Support for Your Mammalian-Derived Products

Mammalian-derived recombinant protein production represents a core capability of Cytovance Biologics. Our extensive experience, combined with our deep technical expertise, has enabled the progression of multiple complex proteins from early phase process development through scaled-up cGMP manufacturing for clinical evaluation. With a broad range of production scales up to 2000L and integrated development capabilities, we offer you both fully custom and platformed approaches to your mammalian biologic’s success.

We provide flexible end-to-end development of all ranges of complex molecules:

• Antibodies
• Fusion Proteins
• Bispecific
• TriKE
• Cytokines
• Enzymes

A 2000L Mammalian Biologics single use biorector at Cytovance Biologics.

Keep Your Molecule Moving Forward

Cytovance's mammalian CDMO services across the drug product lifecycle.

Cell Line Development

Complete mammalian clone selection, clonal stability, and banking services tailored to your requirements.

Mammalian Process Development

Take your productivity to the next level with our process development experts.

Mammalian Analytical Development

Robust analytical method development or transfer personalized for your mammalian-derived biologics.

Mammalian Manufacturing

Benefit from our full-service cGMP facility from cell banks to production with up to 2,000L capacity.

Ingenuity, On Demand

Thought Leadership from Team Cytovance

Production of Therapeutic Proteins in CHO cells

General Scale-Up Strategies: Commonalities Between Mammalian and Microbial Processes

The Power of Partnership

“We recently celebrated successful scale-up and GMP release of the first 1000L DS. We were very lucky to succeed on our first go as a byproduct of Team Cytovance’s hard work.”

— Scientist and Program Lead, Medium Biotech

Meet Team Cytovance in 2026!